1-4 of 4
Ivana Ilić
Close
Sort by
Journal Articles

Clinical Features and Treatment Outcomes of Grey Zone Lymphoma (GZL), Unclassifiable B-Cell Lymphoma with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma - a Real-Life Multicenter Study By the Croatian Cooperative Group for Hematologic Diseases (KroHem)

Ida Hude, Klara Brčić, Martina Morić Perić, Vibor Milunović, Milan Vujčić, Ivan Krecak, Zdravko Mitrović, Božena Coha, Slavko Gašparov, Snježana Dotlić, Ivana Ilić, Sandra Bašić-Kinda, Igor Aurer, Goran Rinčić
Journal: Blood
Blood (2023) 142 (Supplement 1): 7394.
https://doi.org/10.1182/blood-2023-187158
Published: 2023
Journal Articles

Clinicopathological Differences Between Asian and Western Patients with De Novo Diffuse Large B Cell Lymphoma Treated with R-CHOP

Natalie Sinclair, MD, Brady E Beltran, MD, Moo-Kon Song, MD, Ivana Ilic, MD, Sirpa Leppa, Heidy Nyman, MD, Silvia Uccella, MD, Ritsuko Seki, PhD, Jun-ming Li, MD, Diana O Treaba, MD, James N Butera, MD, Jorge J Castillo, MD
Journal: Blood
Blood (2011) 118 (21): 2665.
https://doi.org/10.1182/blood.V118.21.2665.2665
Published: 2011
Journal Articles

The Immunohistochemical Profile and Other Prognostic Factors In Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Treated with R-CHOP

Jorge J Castillo, MD, Brady Beltran, MD, Joo-Seop Chung, MD, Ivana Ilic, MD, Sirpa Leppa, Ritsuko Seki, PhD, Silvia Uccella, MD, Zu-Guang Xia, MD, James N Butera, MD
Journal: Blood
Blood (2010) 116 (21): 4126.
https://doi.org/10.1182/blood.V116.21.4126.4126
Published: 2010
Journal Articles

Dose-Intense BACOP for Treatment of High Risk Peripheral T-Cell NHL (PTCL)

Igor Aurer, MD, PhD, Dino Dujmovic, MD, Ivo Radman, MD, Sandra Basic-Kinda, MD, Damir Nemet, MD, PhD, Ivana Ilic, MD, PhD, Ranka Stern-Padovan, MD, PhD, Fedor Santek, MD, PhD, Dubravka Sertic, MD
Journal: Blood
Blood (2010) 116 (21): 4889.
https://doi.org/10.1182/blood.V116.21.4889.4889
Published: 2010